Runx2 overexpression promotes bone repair of osteonecrosis of the femoral head (ONFH)

被引:7
作者
Xu, Hai-Jia [1 ]
Liu, Xiang-Zhong [1 ]
Yang, Lu [2 ]
Ning, Yu [3 ]
Xu, Liang-Liang [4 ]
Sun, Da-Ming [4 ]
Liao, Wen [1 ]
Yang, Yi [4 ]
Li, Zhang-Hua [1 ]
机构
[1] Wuhan Univ, Wuhan Hosp 3, Tongren Hosp, Dept Orthoped, Wuhan 430060, Peoples R China
[2] Wuhan Univ, Wuhan Hosp 3, Tongren Hosp, Dept Anesthesiol, Wuhan 430060, Peoples R China
[3] Hubei Univ Chinese Med, XiangYang Hosp Tradit Chinese Med, Dept Orthoped, Xiangyang 441000, Peoples R China
[4] Wuhan Sports Univ, Wuhan 430079, Peoples R China
基金
中国国家自然科学基金;
关键词
Osteonecrosis of the femoral head; Mesenchymal stem cells; Runx2; Bone repair; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; AVASCULAR NECROSIS; IN-VITRO; CHONDROGENIC DIFFERENTIATION; INTRAVENOUS TRANSPLANTATION; OSTEOBLAST DIFFERENTIATION; GENE; REGENERATION; EXPRESSION;
D O I
10.1007/s11033-023-08411-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
BackgroundRunt-related transcription factor-2 (Runx2) has been considered an inducer to improve bone repair ability of mesenchymal stem cells (MSCs).Methods and resultsTwenty-four rabbits were used to establish Osteonecrosis of the femoral head (ONFH) and randomly devided into four groups: Adenovirus Runx2 (Ad-Runx2) group, Runx2-siRNA group, MSCs group and Model group. At 1 week after model establishment, the Ad-Runx2 group was treated with 5 x 107 MSCs transfected through Ad-Runx2, the Runx2-siRNA group was treated with 5 x 107 MSCs transfected through Runx2-siRNA, the MSCs group was injected with 5 x 107 untreated MSCs, and the Model group was treated with saline. The injection was administered at 1 week and 3 weeks after model establishment. The expression of bone morphogenetic protein 2 (BMP-2), Runx2 and Osterix from the femoral head was detected at 3 and 6 weeks after MSCs being injected, and Masson Trichrome Staining, Gross Morphology, X-ray and CT images observation were used to evaluate the repair effect of ONFH. The data revealed that the expression of BMP-2, Runx2 and Osterix in the Runx2-siRNA group was reduced at 3 weeks compared with the MSCs group, and then the expression further reduced at 6 weeks, but was still higher than the Model group besides Osterix; The expression of these three genes in the Ad-Runx2 group was higher than in the MSCs group. Masson Trichrome Staining, Gross Morphology and X-ray and CT images observation revealed that necrotic femoral head of the MSCs group was more regular and smooth than the Runx2-siRNA group, which has a collapsed and irregular femoral head. In the Ad-Runx2 group, necrotic femoral head was basically completely repaired and covered by rich cartilage and bone tissue.ConclusionsOverexpression of Runx2 can improve osteoblastic phenotype maintenance of MSCs and promote necrotic bone repair of ONFH.
引用
收藏
页码:4769 / 4779
页数:11
相关论文
共 51 条
[1]   Key transcription factors in the differentiation of mesenchymal stem cells [J].
Almalki, Sami G. ;
Agrawal, Devendra K. .
DIFFERENTIATION, 2016, 92 (1-2) :41-51
[2]   Physical stimulation and scaffold composition efficiently support osteogenic differentiation of mesenchymal stem cells [J].
Asl, Sepide Heydari ;
Hosseinpoor, Hoorieh ;
Parivar, Kazem ;
Roodbari, Nasim Hayati ;
Hanaee-Ahvaz, Hana .
TISSUE & CELL, 2018, 50 :1-7
[3]  
Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724
[4]   Effects of Runx2 genetic engineering and in vitro maturation of tissue-engineered constructs on the repair of critical size bone defects [J].
Byers, BA ;
Guldberg, RE ;
Hutmacher, DW ;
García, AJ .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2006, 76A (03) :646-655
[5]   Synergy between genetic and tissue engineering:: Runx2 overexpression and in vitro construct development enhance in vivo mineralization [J].
Byers, BA ;
Guldberg, RE ;
García, AJ .
TISSUE ENGINEERING, 2004, 10 (11-12) :1757-1766
[6]   Methylsulfonylmethane enhances MSC chondrogenic commitment and promotes pre-osteoblasts formation [J].
Carbonare, Luca Dalle ;
Bertacco, Jessica ;
Marchetto, Giulia ;
Cheri, Samuele ;
Deiana, Michela ;
Minoia, Arianna ;
Tiso, Natascia ;
Mottes, Monica ;
Valenti, Maria Teresa .
STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
[7]   Regulation and Role of Transcription Factors in Osteogenesis [J].
Chan, Wilson Cheuk Wing ;
Tan, Zhijia ;
To, Michael Kai Tsun ;
Chan, Danny .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
[8]   Glucocorticoid-induced loss of beneficial gut bacterial extracellular vesicles is associated with the pathogenesis of osteonecrosis [J].
Chen, Chun-Yuan ;
Rao, Shan-Shan ;
Yue, Tao ;
Tan, Yi-Juan ;
Yin, Hao ;
Chen, Ling-Jiao ;
Luo, Ming-Jie ;
Wang, Zun ;
Wang, Yi-Yi ;
Hong, Chun-Gu ;
Qian, Yu-Xuan ;
He, Ze-Hui ;
Liu, Jiang-Hua ;
Yang, Fei ;
Huang, Fei-Yu ;
Tang, Si-Yuan ;
Xie, Hui .
SCIENCE ADVANCES, 2022, 8 (15)
[9]   YBX1 Promotes MSC Osteogenic Differentiation by Activating the PI3K/AKT Pathway [J].
Chen, Jiayu ;
Liu, Zhanliang ;
Zhang, Huicheng ;
Yang, Yongqian ;
Zeng, Huangxiang ;
Zhong, Rongwei ;
Lai, Shangdao ;
Liao, Hongxing .
CURRENT STEM CELL RESEARCH & THERAPY, 2023, 18 (04) :513-521
[10]   Bioinspired Nanovesicles Convert the Skeletal Endothelium-Associated Secretory Phenotype to Treat Osteoporosis [J].
Cui, Yongzhi ;
Li, Zhongying ;
Guo, Yuanyuan ;
Qi, Xiangbei ;
Yang, Yuehua ;
Jia, Xiong ;
Li, Rui ;
Shi, Jingyu ;
Gao, Weihang ;
Ren, Zhengwei ;
Liu, Guohui ;
Ye, Qingsong ;
Zhang, Zhiping ;
Fu, Dehao .
ACS NANO, 2022, 16 (07) :11076-11091